
- Pharmaceutical Executive-06-01-2008
- Volume 0
- Issue 0
Vlad Hogenhuis, Merck
S
Vlad Hogenhuis
General Manager for Neuroscience, Dermatology, and Ophthalmology, Merck
RECRUITED BY: Merck CEO Roy Vagelos
EXECS NEED: The courage to do what's right
I got a call from Dr. Vagelos, with the opportunity to be part of his mission" is how Vlad Hogenhuis, MD, introduces his 14-year career at Merck. Hogenhuis was getting a Wharton MBA at the time, but he has pharma in his blood. Born in the Netherlands to a long line of physicians—his father developed a migraine drug—he practiced medicine for four years before deciding to jump to industry.
Vlad Hogenhuis
He's climbed the Merck ladder by crossing from managing to managed care to licensing to R&D strategy. "I had a broad view early on," he says. Under CEO Dick Clark's new model integrating clinical and commercial, he directs both the late-stage pipeline and global marketing for a $1.7 billion three-disease franchise. "I have end-to-end accountability," he says. "There's full alignment of what the sales force does and what we do in marketing and even in Phase III."
Articles in this issue
over 17 years ago
Mary Szela, Abbottover 17 years ago
Mightier Than the Swordover 17 years ago
Keeshia Muhammad, Teva Specialty Pharmaceuticalsover 17 years ago
Eric Floyd, Cephalonover 17 years ago
Nancy Phelan, Wyethover 17 years ago
Tightening the Chainover 17 years ago
Kurt Graves, Vertexover 17 years ago
Wendy Niebler, Shireover 17 years ago
Perfectly ImperfectNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.